PABPN 1: molecular function and muscle disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The polyadenosine RNA binding protein polyadenylate‐binding nuclear protein 1 (PABPN 1) plays key roles in post‐transcriptional processing of RNA. Although PABPN 1 is ubiquitously expressed and presumably contributes to control of gene expression in all tissues, mutation of the PABPN 1 gene causes the disease oculopharyngeal muscular dystrophy (OPMD), in which a limited set of skeletal muscles are affected. A major goal in the field of OPMD research is to understand why mutation of a ubiquitously expressed gene leads to a muscle‐specific disease. PABPN 1 plays a well‐documented role in controlling the poly(A) tail length of RNA transcripts but new functions are emerging through studies that exploit a variety of unbiased screens as well as model organisms. This review addresses (a) the molecular function of PABPN 1 incorporating recent findings that reveal novel cellular functions for PABPN 1 and (b) the approaches that are being used to understand the molecular defects that stem from expression of mutant PABPN 1. The long‐term goal in this field of research is to understand the key molecular functions of PABPN 1 in muscle as well as the mechanisms that underlie the pathological consequences of mutant PABPN 1. Armed with this information, researchers can seek to develop therapeutic approaches to enhance the quality of life for patients afflicted with OPMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expansion of the PABPN1 protein occurs within an amino (N) terminal 10-residue alanine tract resulting in the addition of 1–8 alanine residues [1,4,5].”
In the citing paper
“Given that overexpression of wild type (Ala10) PABPN1 alone is sufficient to cause muscle phenotypes [1,23], its overexpression is a confounding factor that must be tightly controlled.”
In the citing paper
“PABPN1 oligomerizes on RNA poly(A) tails [1], so it is likely that the PABPN1-TurboID constructs interact with the endogenous PABPN1 protein.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“As with a number of other polyglutamine and polyalanine expansion diseases, much of the research in the OPMD field has focused on the role of these aggregates [55, 57, 64, 69, 71, 76, 88, 102, 103].”
BackgroundA Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., Tramontano, A., & Bozzoni, I. (2011) · Cell · doi:10.1016/j.cell.2011.09.028 · Cited by 2,554
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
Mechanisms and Consequences of Alternative Polyadenylation
Di Giammartino, D. C., Nishida, K., & Manley, J. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.017 · Cited by 737 · cited 1×
“Alternative polyadenylation plays a key and increasingly appreciated role in modulating gene expression as any change in the length of the 3′-UTR of a transcript can alter interactions with RNA binding proteins as well as microRNAs (miRNAs) significantly impacting transcript stability and translation [31].”
BackgroundShort Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512 · cited 1×
“Indeed, satellite cells isolated from cricopharyngeal muscles of OPMD patients showed defects in cell proliferation in vitro [100] but whether poor cell proliferation results from direct effects of mutant PABPN1 on cellular function or is an indirect affect arising from chronic cycles of degeneration/regeneration in a…”
BackgroundTranslational control by changes in poly(A) tail length: recycling mRNAs
Weill, L., Belloc, E., Bava, F.-A., & Méndez, R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2311 · Cited by 328
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Lim, J., Crespo-Barreto, J., Jafar-Nejad, P., Bowman, A. B., Richman, R., Hill, D. E., Orr, H. T., & Zoghbi, H. Y. (2008) · Nature · doi:10.1038/nature06731 · Cited by 311 · cited 1×
“Variability in protein interactions or altered affinity for critical protein partners of mutant Ataxin-1 has been previously demonstrated to contribute to disease pathogenesis in spinocerebellar ataxia 1, a polyglutamine expansion disorder [113].”
BackgroundDavies, J. E., Sarkar, S., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi422 · Cited by 207
Alternative Polyadenylation Mediates MicroRNA Regulation of Muscle Stem Cell Function
Boutet, S. C., Cheung, T. H., Quach, N. L., Liu, L., Prescott, S. L., Edalati, A., Iori, K., & Rando, T. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.01.017 · Cited by 150
Lemay, J.-F., D'Amours, A., Lemieux, C., Lackner, D. H., St-Sauveur, V. G., Bähler, J., & Bachand, F. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.019 · Cited by 112 · cited 14×
“Additional studies demonstrate that Pab2 interacts with components of the nuclear exosome (Rrp6 and Dis3) and plays a role in the synthesis of small non-coding nucleolar RNAs (snoRNA) (Fig.”
BackgroundInfluential
Cited by
Dzik, K. P., & Kaczor, J. J. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04104-x · Cited by 357
“It was reported that IGF-1 signalling induces anabolism, being upregulated during resistance exercise, and this influences the IGF- 1–Akt–FOXO pathway (Perrini et al. 2010; Banerjee et al. 2013; Bonaldo et al. 2013).”
BackgroundPost-transcriptional regulation of gene expression and human disease
Corbett, A. H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.02.011 · Cited by 189
Self-citationThe RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging
D’Amico, D., Mottis, A., Potenza, F., Sorrentino, V., Li, H., Romani, M., Lemos, V., Schoonjans, K., Zamboni, N., Knott, G., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.034 · Cited by 159
“A few relevant examples include the RBPs FUS and TDP-43, in the context of amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) (Gitler and Shorter, 2011); PABPN1 in the oculopharyngeal muscular dystrophy (OPMD) (Banerjee et al., 2013), and TIA1 in Tau-…”
BackgroundMezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Metadata
- Authors
- Banerjee, A., Apponi, L. H., Pavlath, G. K., & Corbett, A. H.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-05-24
- Volume
- 280
- Issue
- 17
- Pages
- 4230-4250
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2052653618
- Cited by
- 138
- References
- 11
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PABPN 1: molecular function and muscle disease. https://app.cochat.ai/papers/10.1111/febs.12294
- The paper
- Banerjee, A., Apponi, L. H., Pavlath, G. K., & Corbett, A. H. (2013). PABPN 1: molecular function and muscle disease. The FEBS Journal. https://doi.org/10.1111/febs.12294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.